A Phase 2 Study of Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Capecitabine (Primary) ; Peginterferon alfa-2b (Primary) ; Fluorouracil
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 30 May 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Apr 2017 Planned End Date changed from 1 Sep 2017 to 1 Apr 2018.
- 21 Apr 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Apr 2018.